Learn More
OBJECTIVE To compare tumor necrosis factor alpha inhibitors directly regarding the rates of treatment response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), and(More)
OBJECTIVES To describe drug survival, disease activity and clinical response in patients with rheumatoid arthritis (RA) treated with abatacept or tocilizumab in routine care, based on prospectively(More)
OBJECTIVES To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug(More)
OBJECTIVES To investigate the incidence of cancer in arthritis patients treated with or without TNFα inhibitors (TNF-I). METHODS Arthritis patients from the DANBIO database were followed-up for(More)